| 000 | 01190 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513182948.0 | ||
| 264 | 0 | _c19990603 | |
| 008 | 199906s 0 0 eng d | ||
| 022 | _a0041-1345 | ||
| 024 | 7 |
_a10.1016/s0041-1345(99)00085-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJohnston, A | |
| 245 | 0 | 0 |
_aBioequivalence criteria for cyclosporine. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cMay 1999 |
||
| 300 |
_a1649-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacokinetics |
| 650 | 0 | 4 | _aDrugs, Generic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aRacial Groups |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 650 | 0 | 4 | _aTransplantation Immunology |
| 700 | 1 | _aHolt, D W | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 31 _gno. 3 _gp. 1649-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0041-1345(99)00085-8 _zAvailable from publisher's website |
| 999 |
_c10289863 _d10289863 |
||